ES2101000T3 - Uso de bmy 14802 en el tratamiento de la ansiedad en pacientes con sindrome de abstinencia de benzodiazepinas. - Google Patents

Uso de bmy 14802 en el tratamiento de la ansiedad en pacientes con sindrome de abstinencia de benzodiazepinas.

Info

Publication number
ES2101000T3
ES2101000T3 ES92118219T ES92118219T ES2101000T3 ES 2101000 T3 ES2101000 T3 ES 2101000T3 ES 92118219 T ES92118219 T ES 92118219T ES 92118219 T ES92118219 T ES 92118219T ES 2101000 T3 ES2101000 T3 ES 2101000T3
Authority
ES
Spain
Prior art keywords
treatment
bmy
anxiety
patients
withdrawal syndrome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92118219T
Other languages
English (en)
Spanish (es)
Inventor
Frank D Yocca
Herbert L Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of ES2101000T3 publication Critical patent/ES2101000T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ES92118219T 1991-10-24 1992-10-23 Uso de bmy 14802 en el tratamiento de la ansiedad en pacientes con sindrome de abstinencia de benzodiazepinas. Expired - Lifetime ES2101000T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US78201091A 1991-10-24 1991-10-24

Publications (1)

Publication Number Publication Date
ES2101000T3 true ES2101000T3 (es) 1997-07-01

Family

ID=25124656

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92118219T Expired - Lifetime ES2101000T3 (es) 1991-10-24 1992-10-23 Uso de bmy 14802 en el tratamiento de la ansiedad en pacientes con sindrome de abstinencia de benzodiazepinas.

Country Status (18)

Country Link
US (1) US5278164A (enExample)
EP (1) EP0538897B1 (enExample)
JP (1) JPH05238934A (enExample)
KR (1) KR100196334B1 (enExample)
AT (1) ATE150645T1 (enExample)
AU (1) AU649169B2 (enExample)
CA (1) CA2081062A1 (enExample)
CY (1) CY2019A (enExample)
DE (1) DE69218544T2 (enExample)
DK (1) DK0538897T3 (enExample)
ES (1) ES2101000T3 (enExample)
GR (1) GR3022945T3 (enExample)
HK (1) HK113897A (enExample)
IL (1) IL103499A0 (enExample)
OA (1) OA09766A (enExample)
PH (1) PH30028A (enExample)
TW (1) TW217382B (enExample)
ZA (1) ZA928105B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011091418A1 (en) * 2010-01-25 2011-07-28 Northeastern University Screening method for adverse side effects of a therapeutic pharmaceutical drug

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4605655A (en) * 1984-03-06 1986-08-12 Bristol-Myers Company Antipsychotic 1-fluorophenylbutyl-4-(2-pyrimidinyl)piperazine derivatives
US5055470A (en) * 1989-06-01 1991-10-08 Bristol-Myers Squibb Co. Method of treatment of ischemia in brain

Also Published As

Publication number Publication date
HK113897A (en) 1997-08-29
JPH05238934A (ja) 1993-09-17
KR930007452A (ko) 1993-05-20
TW217382B (enExample) 1993-12-11
AU2716592A (en) 1993-04-29
DK0538897T3 (da) 1997-08-25
OA09766A (en) 1993-11-30
GR3022945T3 (en) 1997-06-30
PH30028A (en) 1996-11-08
ZA928105B (en) 1993-08-25
DE69218544T2 (de) 1997-11-13
US5278164A (en) 1994-01-11
DE69218544D1 (de) 1997-04-30
CY2019A (en) 1998-02-20
ATE150645T1 (de) 1997-04-15
EP0538897A1 (en) 1993-04-28
KR100196334B1 (ko) 1999-06-15
AU649169B2 (en) 1994-05-12
CA2081062A1 (en) 1993-04-25
IL103499A0 (en) 1993-03-15
EP0538897B1 (en) 1997-03-26

Similar Documents

Publication Publication Date Title
DE69333607D1 (de) Vorrichtung zur Herstellung von vorgefüllten, sterilen Abgabevorrichtungen
HUT63564A (en) Medical preparatives, method for producing them and their applications as analgetic and/or febrifuge in human and veterinary medicine
DE69423842D1 (de) Medizinisches Gerät mit Patiententisch
DE69206378D1 (de) Patientenliegetische.
BR9913932A (pt) Uso de análogos de glp-1 no tratamento de derrame
IT8709354A0 (it) Siringa per iniezioni,in specie endovenose,realizzata per poteressere usata una sola volta,senza possibilita' di riaspirazione.
DE69203990D1 (de) Einrichtung zur transdermalen Verabreichung von Medikamenten.
FI940850A7 (fi) Laite lääkkeen annostelemiseksi ihon kautta
DE69110785D1 (de) Narkosemittelverdampfer.
DK0998287T3 (da) Anvendelse af levobupivacain
HU9301253D0 (en) Medical preparative applicable for treatment of enlarged time of coagulation
DE59009354D1 (de) Zahnärztlicher Patientenstuhl.
KR950702120A (ko) 골다공증 치료를 위한 포스포네이트의 용도(use of phosphonates for the treatment of osteoporosis)
ES2181702T3 (es) Derivados de melatonina para su uso en el tratamiento de enfermedad es del sueño.
ES2101000T3 (es) Uso de bmy 14802 en el tratamiento de la ansiedad en pacientes con sindrome de abstinencia de benzodiazepinas.
ITMI910381A1 (it) Medicamento per il trattamento della dermatite
DE69331008D1 (de) Verwendung von cotinin zur linderung des tabakentzugssyndrom
NO960545D0 (no) Behandling av skadelige virkninger i forbindelse med administrering av ekstracellulært hemoglobin
ES2072869T3 (es) Uso de derivados de la 1,4-dihidropiridina en el tratamiento del alcoholismo.
SE9101341D0 (sv) New medicinal use
DK0711163T3 (da) Anvendelse af benzydamin i behandlingen af patologiske tilstande forårsaget af TNF
KR900017599A (ko) 종양 치료용 약학 조성물
IL98200A0 (en) Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide
ITMI920261V0 (it) Vaporizzatore per scopi medicali e cosmetici
DK0495721T3 (da) Anvendelsen af et polypeptid med en humant-interleukin-2-aktivitet til fremstilling af farmaceutiske præparater beregnet til behandling af pneumothorax

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 538897

Country of ref document: ES